H2

H2 EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of H2 (7851.TWO) as of Oct 22, 2026 is -19.39. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was -19.77 — a change of -1.94% (higher).

EV/OCF

-19.39

YoY

-1.94%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of H2 is 2024 -19.39 . EV/OCF (Enterprise Value to Operating Cash Flow) of H2 was 2023 -19.77 . It decreases by -1.94% higher compared to the previous year.

The H2 EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2023
-19.77 TWD
Jan 1, 2024
-19.39 TWD
The H2 EV/OCF history
YEAREV/OCFYoY
-19.39-1.94%
-19.77—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

H2 Stock analysis

What does H2 do? H2 Inc generates revenue through its Health2Sync App, which offers a premium membership providing deeper analysis of health readings and educational content. The Patient Management Platform is sold to healthcare providers for patient prioritization and data-driven insights. Data Syncing supports integration with blood glucose meters, blood pressure monitors, weight scales, insulin pens, and CGMs, enabling seamless data import from various devices. The company serves healthcare providers, patients managing chronic conditions, and partners offering care services. Health2Sync App targets patients seeking daily management of chronic diseases through mobile and digital therapeutics, with features like tracking trends and receiving reminders. Premium members access advanced analytics and educational resources. The Patient Management Platform caters to healthcare organizations needing instant platform deployment and improved communication tools. Data Syncing facilitates connectivity with supported devices including CGM and insulin pen apps, enhancing user experience across the ecosystem. The company monetizes through subscription-based premium memberships for individual users and licensing fees for the Patient Management Platform to healthcare institutions. Data Syncing is integrated into the core product suite, driving adoption through device compatibility. Healthcare providers, chronic disease patients, and care partners form the primary customer segments purchasing these solutions. H2 is one of the most popular companies on Eulerpool.

Frequently Asked Questions about H2 stock

EV/OCF (Enterprise Value to Operating Cash Flow) of H2 is -19.39 in 2024.

EV/OCF (Enterprise Value to Operating Cash Flow) of H2 changed from -19.77 to -19.39, representing a -1.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) H2 since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s H2 with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — H2

All Key Metrics — H2